Table 3 Blood cell counts in CD2F1 mice 14 days after IL-18BP or vehicle treatment.

From: IL-18 binding protein (IL-18BP) as a novel radiation countermeasure after radiation exposure in mice

Treatment

WBC (× 103)

NEU (× 103)

LYM (× 103)

MONO (× 103)

RBC (× 103)

HGB (g/dL)

PLT (× 103)

Vehicle

6.55 ± 2.37

1.54 ± 0.66

4.34 ± 1.55

0.16 ± 0.08

8.82 ± 1.70

12.78 ± 2.94

1001.00 ± 217.74

IL-18BP

0.25 mg/kg

4.83 ± 0.71

1.04 ± 0.16

3.38 ± 0.60

0.09 ± 0.06

9.22 ± 0.48

13.07 ± 0.56

1055.67 ± 81.99

0.5 mg/kg

4.36 ± 1.73

0.98 ± 0.13

3.55 ± 1.67

0.05 ± 0.04

7.91 ± 2.50

10.20 ± 3.65 *

921.67 ± 382.38

1.0 mg/kg

6.51 ± 1.24

1.45 ± 0.43

4.62 ± 0.84

0.17 ± 0.09

8.93 ± 0.56

13.40 ± 0.95

960.17 ± 142.65

1.5 mg/kg

6.32 ± 1.63

1.02 ± 0.53

4.74 ± 1.07

0.14 ± 0.09

8.60 ± 0.59

13.07 ± 0.76

1075.33 ± 114.34

2.0 mg/kg

3.99 ± 1.09 *

0.64 ± 0.20 *

3.60 ± 0.86

0.11 ± 0.05

7.77 ± 2.18

11.85 ± 3.28

775.17 ± 267.59

3.0 mg/kg

5.55 ± 1.32

1.26 ± 0.41

3.89 ± 0.88

0.15 ± 0.02

9.35 ± 0.37

14.20 ± 0.3

1008.00 ± 76.28

5.0 mg/kg

7.99 ± 0.63

1.54 ± 0.30

5.88 ± 0.44

0.23 ± 0.12

9.59 ± 0.38

14.43 ± 0.55

1010.33 ± 179.73

  1. Mouse blood were collected and blood cell counts were evaluated. IL-18BP-treated vs. vehicle control-treated. *p < 0.05: (N = 6).